Levy Noah G.'s Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Jul 13, 2022
- Accession no.
- 0000899243-22-026020
- Filed
- Jul 13, 2022, 4:05 PM ET
- Trade date
- Jul 11-12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $20.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levy Noah G.CIK 0001788608 | Director, Other: See remarks |
| Newtyn Partners, LPCIK 0001548707 | Other: See Remarks |
| Newtyn TE Partners, LPCIK 0001548709 | Other: See Remarks |
| Newtyn Management, LLCCIK 0001569241 | Other: See Remarks |
| Newtyn Capital Partners, LPCIK 0001789643 | Other: See Remarks |
| Ledo Capital, LLCCIK 0001789647 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2022 | Common Stock | PPurchaseAcquired | +700 | $5.97 | +$4,181.59 | 748,197 | Indirect | |
| Jul 12, 2022 | Common Stock | PPurchaseAcquired | +2,816 | $5.86 | +$16,515.56 | 751,013 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.